Development proposal for Biopharmaceutical Industry
我国生物医药企业发展建议

Biotech is currently the fastest growing sector in the drug industry. Globally biotech products generated revenues of $55bn in 2004, in a total drug market worth $550bn. The USA is the primary market for biotech products, being the source of approximately half of sales in 2004. 54.5% of biopharmaceuticals' sales in 2004 came from the leading 5 products. Great progress has been made in the Chinese biotech market over the last few years. About 60%-70% of recombinant protein biopharmaceuticals are expressed by mammalian cell in USA and EU, while most recombinant protein biopharmaceuticals are expressed by E.coli in China. Most biopharmaceuticals expressed by mammalian cell can't be manufactured in China. The biotech industry comprise numerous, mostly small organization. Each one typically employs fewer than 100 people. Most biotech companies have never brought a product to market before they come to die. Making a appropriate development strategy for biotech company is very necessary.